Kala Pharmaceuticals Inc (KALA)
NASDAQ:KALA
Holding KALA?
Track your performance easily

Kala Pharmaceuticals (KALA) Financial Statements

1,448 Followers

Kala Pharmaceuticals Financial Overview

Kala Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-13.951; its P/E ratio is -0.55; Kala Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -9.58M$ -11.27M$ -7.16M$ -7.25M$ -9.00M
EBITDA$ -9.20M$ -10.89M$ -7.09M$ -7.17M$ -8.62M
Net Income Common Stockholders$ -9.58M$ -11.81M$ -8.63M$ -8.70M$ -10.41M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 54.20M$ 48.48M$ 50.90M$ 56.06M$ 59.18M
Total Assets$ 61.61M$ 53.03M$ 55.95M$ 61.12M$ 66.50M
Total Debt$ 36.80M$ 36.56M$ 36.32M$ 36.08M$ 33.57M
Net Debt$ -17.40M$ -11.92M$ -14.57M$ -19.98M$ -25.61M
Total Liabilities$ 47.89M$ 46.37M$ 48.45M$ 49.90M$ 49.01M
Stockholders Equity$ 13.72M$ 6.66M$ 7.50M$ 11.22M$ 17.49M
Cash Flow-
Free Cash Flow$ -9.21M$ -10.84M$ -7.70M$ -3.23M$ -7.44M
Operating Cash Flow$ -9.21M$ -10.84M$ -7.70M$ -2.95M$ -7.59M
Investing Cash Flow$ -36.00K$ -13.00K$ -7.00K$ 9.72M$ -10.03M
Financing Cash Flow$ 14.97M$ 8.44M$ 2.54M$ 40.00K$ 3.07M
Currency in USD

Kala Pharmaceuticals Earnings and Revenue History

Kala Pharmaceuticals Debt to Assets

Kala Pharmaceuticals Cash Flow

Kala Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis